Shares of Medical Specialities company Natera climbed 1.8% this evening. Here are some quick facts to get you started if you are interested in the stock:
-
Natera has logged a 124.8% 52 week change, compared to 23.2% for the S&P 500
-
NTRA has an average analyst rating of buy and is -9.9% away from its mean target price of $123.41 per share
-
Its trailing earnings per share (EPS) is $-3.11, which brings its trailing Price to Earnings (P/E) ratio to -35.8. The Health Care sector's average P/E ratio is 27.53
-
The company's forward earnings per share (EPS) is $-1.19 and its forward P/E ratio is -93.4
-
The company has a Price to Book (P/B) ratio of 17.11 in contrast to the Health Care sector's average P/B ratio is 3.61
-
The current ratio is currently 4.1, which consists in its liquid assets divided by any liabilities due within in the next 12 months
-
The company's free cash flow for the last fiscal year was $-286154000 and the average free cash flow growth rate is -32.0%
-
Natera's revenues have an average growth rate of 31.1% with operating expenses growing at 27.9%. The company's current operating margins stand at -41.2%